ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Director, Pharmaceutical Delivery at AbCellera - ApplyBlast

Director, Pharmaceutical Delivery

AbCellera

1 month ago

3.6 on Glassdoor

Vancouver, British Columbia, Canada

Onsite

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Director, Pharmaceutical Delivery leads the technical development and commercialization of drug-device combination products, including prefilled syringes and autoinjectors. This role involves architecting design control frameworks, managing strategic supplier partnerships, and ensuring compliance with global regulatory standards. The position requires close collaboration with cross-functional teams to advance products from clinical development through commercial launch.

Responsibilities

Lead design control framework and device development for combination products
Oversee regulatory documentation and submissions for global clinical and commercial approvals
Manage external device partners and CDMOs to advance product development

Skills

Qualifications

Bachelor's degree in mechanical, biomedical, or chemical engineeringpost-graduate degree in mechanical, biomedical, or chemical engineering

About AbCellera

abcellera.com

Headquarters

Vancouver, British Columbia, Canada

Company Size

501-1000 employees

Founded

2012

View Profile

AbCellera is a biotechnology company that discovers and develops therapeutic antibodies using a proprietary high-throughput single‑cell screening platform combined with machine learning and large immune datasets. It partners with pharma and biotech to rapidly identify and optimize antibody leads and also advances its own pipeline of first‑in‑class and best‑in‑class programs across multiple indications and modalities. The platform is designed to accelerate target‑to‑candidate timelines and has been used in rapid-response collaborations and clinical‑stage antibody programs.